Yodit Seifu

1.2k total citations
40 papers, 896 citations indexed

About

Yodit Seifu is a scholar working on Statistics and Probability, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Yodit Seifu has authored 40 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Statistics and Probability, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Surgery. Recurrent topics in Yodit Seifu's work include Statistical Methods in Clinical Trials (8 papers), Blood Pressure and Hypertension Studies (6 papers) and Statistical Methods and Inference (6 papers). Yodit Seifu is often cited by papers focused on Statistical Methods in Clinical Trials (8 papers), Blood Pressure and Hypertension Studies (6 papers) and Statistical Methods and Inference (6 papers). Yodit Seifu collaborates with scholars based in United States, Canada and United Kingdom. Yodit Seifu's co-authors include Christine Curtis, David Andrews, Ronald M. Zuker, Bryan J. Michelow, Howard M. Clarke, Klemens Budde, Greg Knoll, John J. Curtis, Lawrence Chan and Michael Hall and has published in prestigious journals such as Ecology, Hypertension and The Journal of Urology.

In The Last Decade

Yodit Seifu

37 papers receiving 867 citations

Peers

Countries citing papers authored by Yodit Seifu

Since Specialization

Citations

This map shows the geographic impact of Yodit Seifu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yodit Seifu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yodit Seifu more than expected).

Fields of papers citing papers by Yodit Seifu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yodit Seifu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yodit Seifu. The network helps show where Yodit Seifu may publish in the future.

Co-authorship network of co-authors of Yodit Seifu

This figure shows the co-authorship network connecting the top 25 collaborators of Yodit Seifu. A scholar is included among the top collaborators of Yodit Seifu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yodit Seifu. Yodit Seifu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time‐to‐event outcomes 2022 ·Pharmaceutical Statistics ·Gaohong Dong, Bo Huang, Johan Verbeeck, Ying Cui, James Song, Margaret Gamalo, Duolao Wang, David C. Hoaglin, Yodit Seifu, (unknown), John E. Kolassa	30
2	The win odds: statistical inference and regression 2022 ·Journal of Biopharmaceutical Statistics ·James Song, Johan Verbeeck, Bo Huang, David C. Hoaglin, Margaret Gamalo, Yodit Seifu, Duolao Wang, (unknown), Gaohong Dong	11
3	Design of paediatric trials with benefit-risk endpoints using a composite score of adverse events of interest (AEI) and win-statistics 2022 ·Journal of Biopharmaceutical Statistics ·Yodit Seifu, Shahrul Mt‐Isa, (unknown), Margaret Gamalo, William Yang Wang, Gaohong Dong, John E. Kolassa	2
4	Real-World Evidence Utilization in Clinical Development Reflected by US Product Labeling: Statistical Review 2020 ·Therapeutic Innovation & Regulatory Science ·Yodit Seifu, Margaret Gamalo, (unknown), (unknown), Junshan Qiu, (unknown), (unknown), Rosalind Walley	11
5	Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection 2020 ·Fertility and Sterility ·Craig A. Witz, Gaurang S. Daftary, Kevin J. Doody, John K. Park, Yodit Seifu, Vladimir I. Yankov, Patrick W. Heiser	26
6	The win ratio: Impact of censoring and follow‐up time and use with nonproportional hazards 2019 ·Pharmaceutical Statistics ·Gaohong Dong, Bo Huang, Yu‐Wei Chang, Yodit Seifu, James Song, David C. Hoaglin	21
7	Efficacy and safety of a ready-to-drink bowel preparation for colonoscopy: a randomized, controlled, non-inferiority trial 2019 ·Therapeutic Advances in Gastroenterology ·Lawrence Hookey, Gerald Bertiger, (unknown), (unknown), Yodit Seifu, Stuart Brogadir	8
8	Statistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive of Fabrication or Misconduct 2016 ·Therapeutic Innovation & Regulatory Science ·(unknown), Anne S. Lindblad, Gaurav Sharma, Gary Gensler, Zorayr Manukyan, Abigail G. Matthews, Yodit Seifu	11
9	MP72-16 SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF LIRIS® 400 MG IN WOMEN WITH ULCERATIVE INTERSTITIAL CYSTITIS 2016 ·The Journal of Urology ·Kenneth M. Peters, Yodit Seifu, (unknown), (unknown)	4
10	Nonparametric Multivariate Inference on Shift Parameters 2013 ·Academic Radiology ·John E. Kolassa, Yodit Seifu	3
11	Time-to-effect with darifenacin in overactive bladder: a pooled analysis 2011 ·International Urogynecology Journal ·Vik Khullar, Jenelle E. Foote, Yodit Seifu, (unknown)	4
12	Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy 2010 ·Journal of Hypertension ·Suzanne Oparil, Thomas D. Giles, Elizabeth Ofili, Bertram Pitt, Yodit Seifu, Robert Hilkert, Rita Samuel, James R. Sowers	9
13	INTENSIVE TREATMENT WITH COMBINATION AMLODIPINE/VALSARTAN VS MODERATE THERAPY FOR HYPERTENSIVE PATIENTS WITH DIABETES OR CKD UNCONTROLLED ON ARB MONOTHERAPY: PP.17.149 2010 ·Journal of Hypertension ·James R. Sowers, Thomas D. Giles, Elizabeth Ofili, Bertram Pitt, Yodit Seifu, Rita Samuel, Robert Hilkert, Suzanne Oparil	1
14	GREATER EFFICACY WITH AMLODIPINE/VALSARTAN COMBINATION INTENSIVE VS MODERATE TREATMENT FOR HYPERTENSIVE PATIENTS WITH CARDIOMETABOLIC SYNDROME UNCONTROLLED ON ARB MONOTHERAPY: PP.34.432 2010 ·Journal of Hypertension ·James R. Sowers, Thomas D. Giles, Elizabeth Ofili, Bertram Pitt, Yodit Seifu, Rita Samuel, Robert Hilkert, Suzanne Oparil	1
15	Validation of the Differential Cardiovascular Effects of the Antimuscarinic Agents Darifenacin and Tolterodine in a Randomized, Placebo-Controlled, 3-Way Crossover Study 2009 ·UroToday International Journal ·Brian Olshansky, Egilius L.H. Spierings, José M. Brum, (unknown), (unknown), Yodit Seifu	4
16	Initial Combination Therapy Compared With Monotherapy in Diabetic Hypertensive Patients 2008 ·Journal of Clinical Hypertension ·James R. Sowers, Guido Lastra, Ricardo Rocha, Yodit Seifu, (unknown), Drew Levy	8
17	Safety and Efficacy After Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium: Results of a 1-Year Extension Study 2005 ·Transplantation Proceedings ·Klemens Budde, Greg Knoll, John J. Curtis, Lawrence Kahana, Erich Pohanka, Yodit Seifu, H.‐H. Neumayer	19
18	Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year Study 2004 ·American Journal of Transplantation ·Klemens Budde, John J. Curtis, Greg Knoll, Lawrence Chan, Hans‐Hellmut Neumayer, Yodit Seifu, Michael Hall	206
19	Persistent stress-induced elevations of urinary corticosterone in rats 2000 ·Physiology & Behavior ·Francis X. Brennan, John E. Ottenweller, Yodit Seifu, (unknown), Richard J. Servatius	32
20	The Natural History of Obstetrical Brachil Plexus Palsy 1994 ·Plastic & Reconstructive Surgery ·Bryan J. Michelow, Howard M. Clarke, Christine Curtis, Ronald M. Zuker, Yodit Seifu, David Andrews, John P. Laurent	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact